Scheme of Arrangement
Royal Sense Withdraws Merger Scheme
Royal Sense Limited’s board decided to withdraw the proposed merger scheme with TTG Innovations Private Limited and will file a withdrawal application with the NCLT Delhi Bench.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Investor Presentation
Q4 FY26
Investor Presentation
Q2 FY26
Scheme of Arrangement
Royal Sense Limited’s board decided to withdraw the proposed merger scheme with TTG Innovations Private Limited and will file a withdrawal application with the NCLT Delhi Bench.
Financial Results
Royal Sense approved unaudited standalone financial results for the half year ended September 30, 2026, along with the statutory auditor’s limited review report.
Royal Sense Ltd (ROYAL) is currently trading at 63.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Royal Sense Limited is a Delhi-headquartered medical supplies and distribution company supplying surgical instruments, consumables, laboratory equipment, diagnostics, pharmaceuticals and sanitary products, formed by consolidating three prior proprietorship businesses and operating a retail/wholesale distribution model including a wholly owned subsidiary, Stergic Retail Private Limited. For the year ended March 31, 2026 the company filed audited standalone and consolidated financials with an unmodified auditor opinion; consolidated reported income from operations in the investor presentation is materially higher than standalone results, reflecting significant contribution from the Stergic Retail subsidiary and an expanded product and customer footprint. Capital formation events include a March 2024 IPO raising approximately Rs 9.86 crore and a December 2025 issuance of share warrants whose proceeds were certified by auditors and utilised primarily for working capital and general corporate purposes, demonstrating recent successful equity fundraising to support growth. Governance and scale-up signals include revision of the ESOP plan, formation of a Funds Management Committee and a Procurement and Compliance Approval Committee, and approval of management remuneration, which together indicate Royal Sense Limited is professionalizing governance to manage accelerated procurement, inventory and fund deployment as it scales operations.
Over the past 52 weeks, Royal Sense Ltd has traded between a low of ₹61.01 and a high of ₹255.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Royal Sense Ltd has a market capitalization of approximately 33.71. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Royal Sense Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 4.96 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 33.71 Cr, Royal Sense Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Royal Sense Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Royal Sense Ltd is 4.96. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Royal Sense said on November 17, 2026 that its board had decided not to proceed with the proposed merger and had resolved to withdraw the scheme. The announcement covers the scheme involving TTG Innovations and the respective shareholders of both companies.
Royal Sense Ltd announced that its board declared unaudited financial results for the half-year ended September 30, 2026. The supplied material does not include the detailed financial statements or headline revenue and profit figures.
Royal Sense reported a consolidated operating cash outflow of Rs 3.99 crore for the half year ended September 30, 2026. Its largest disclosed working-capital movement was a Rs 16.56 crore increase in trade receivables, and inventories increased by Rs 1.46 crore.
Royal Sense will hold its board meeting on November 14, 2026. The board will consider unaudited standalone and consolidated results for the half year ended September 30, 2026.
Healthcare Equipment & Supplies
Medical Equipment & Supplies
34 Cr
High Risk
5.0
60.1
0.4
0.9
255.90
61.01
Sales CAGR
Profit CAGR
ROE
ROCE
Bearish
3
Neutral
2
Bullish
9
Bearish
35
Neutral
2
Bullish
9
Bearish
32
Neutral
0
Bullish
0
View Standalone
View Standalone
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone